Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
6.17
↓ 98% below average
Average (9y)
342.22
Historical baseline
Range
High:2309.17
Low:6.17
CAGR
-48.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2025 | 6.17 | -99.3% |
| 2024 | 864.39 | +6493.3% |
| 2023 | 13.11 | -7.8% |
| 2022 | 14.22 | -68.9% |
| 2021 | 45.69 | -4.6% |
| 2020 | 47.90 | +233.7% |
| 2019 | 14.36 | -85.3% |
| 2018 | 97.81 | +943.4% |
| 2017 | 9.37 | -99.6% |
| 2016 | 2309.17 | - |